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To evaluate the association between an indicator ofcarcinogen exposure (peripheral blood leukocyte DNA adducts of
polycyclic aromatichydrocarbons) andanearlyindicatorofneoplastictransformation (sputumepithelialcellmembrane
antigensbindingbymonoclonalantibodiesagainstsmallcelllungcancerandagainst nonsmallcelllungcancer), asurvey
of350coke-ovenworkersand 100unexposedworkerswasplanned. Thispaperreportsapilotinvestigationonasubgroup
of23coke-oven workers and8unexposed controls. A "gasregulator" worker with positivetumorantigenbinding was
identified. Resultsshowthatsmokers,subjectswithdecreasedpulmonaryfunction(forcedexpiratoryvolumein1 sec/forced
vital capacity% <80), and those with morphological dysplasiaofsputum cells havehigherlevels ofDNA adducts. The
gas regulators showed thehighest values foradducts; however, nosignificant differenceofadduct levels was found bet-
ween thecoke-oven group andunexposed controls.
Introduction
Cokeovenworkersareknowntohaveanincreasedlungcancer
risk (1). A lung cancer-oriented monitoringprogramamong 350
coke-oven workers inasteelmill inSouthernItaly was initiated
withthe followingaims: a)toassessthefrequencyofpositiveim-
munostainingbymonoclonalantibodiesthatbindtocellsurface
lung cancer (small cell lung cancer [SCLC] and nonsmall cell
lung cancer [NSCLC]) differentiation antigens insputumcells
ofcokeoven workerswithandwithoutmorphologicalatypia; b)
to detect DNA adducts of polycyclic aromatic hydrocarbons
(PAH) in lymphocytes using anenzyme-linked immunosorbent
assay (ELISA); c) to examine the association between PAH-
DNA adducts and positive tumor-specific immunostaining
among coke-oven workers (afteradjustmentfortobacco smok-
ing andcharcoal-broiled foodconsumption); andd) toexamine
theassociationsbyjobtitles. Thispaperisareportofapilotin-
vestigation conducted inOctober 1988onasubgroupof23coke-
oven workers who showed squamous metaplasia or light/-
moderate atypia ofsputum cells in aprevious survey (2). This
subgroup was chosen because subjects with morphologically
altered sputum cells may be more likely to show positive
immunostaining.
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Materials and Methods
Thecokery under study is located in the steel plantofTaran-
to(Italy)andconsistsof 11 batteriesbuiltbetween 1964and 1976.
Inthefirstsurvey (2), 35 workers withsquamousmetaplasiaor
light/moderate dysplasiaofsputumcells wereidentifiedamong
524workersscreened; ofthese, 12 were retired and23 (19 with
squamous metaplasia and4with light/moderatedysplasia) were
stillemployedinOctober 1988. Everyworkerunderwentblood
drawing (35 mL), sputum induction, spirometry, and a ques-
tionnaire-interview. Alldatarelatedtothedemographic, occupa-
tional, smoking habits, history of respiratory symptoms and
diseases were collected by standardized questionnaire and
reviewed by anoccupational physician.
PAH-DNAAdducts Measurements
After centrifugation ofwhole blood, nucleated blood cells
wereremoved fromthe serum-hemoglobin interface and DNA
wasextractedbyhigh-saltfractionation (3) followedbychloro-
form-isoamyl alcohol extraction. Measurement ofPAH-DNA
adducts was performed by ELISA as previously described (4)
with anti-benzo[a]pyrene-modified DNA (BaP-DNA) an-
tiserum, a standard curve (BaP-DNA) modified in the same
range as the biological samples, and a fluorescent methyl-
umbelliferyl-phosphate substrate. Because the antiserum cross-
reacts with DNA modified with multiple PAHs (5), the values
generated reflectthemany PAHs towhichhumans areexposed
and are termed "PAH-DNA adducts." The lower limit ofsen-
sitivity, by comparison with the (above) BaP-DNA standard
curve, is inthe rangeof0.04 fmoleadducts/tg DNA. Levels ofASSENNATOETAL.
Table 1. Age, levels ofPAH-DNA adducts, severity ofatypiaby Papanicolaou method, smoking habits, pulmonary function (FVC, FEV,),
andjobtitleof23 coke-oven workers.
Age Jobtitle
47 Top side
32 Bench
39 Maintenance
45 Supervisor
41 Maintenance
48 Gas regulator
49 Bench
40 Bench
46 Gas regulator
42 Supervisor
37 Maintenance
39 Bench
32 Bench
32 Bench
55 Maintenance
35 Bench
44 Gas regulator
42 Bench
35 Bench
41 Maintenance
39 Bench
40 Supervisor
39 Top side
Cigarettes
smoked/day
Ex-smoker
0
0
20
30
5
Ex-smoker
Ex-smoker
15
Ex-smoker
20
Ex-smoker
0
20
0
15
30
Ex-smoker
20
20
30
0
20
Cytomorphology
Squamous metaplasia
Squamous metaplasia
Squamous metaplasia
Squamous metaplasia
Squamous metaplasia
Moderate dysplasia
Moderate dysplasia
Moderate dysplasia
Normal
Normal
Squamous metaplasia
Normal
Squamous metaplasia
Squamous metaplasia
Squamous metaplasia
Squamous metaplasia
Moderate dysplasia
Normal
Squamous metaplasia
Normal
Squamous metaplasia
Normal
Normal
Abbreviations: FVC, forcedvital capacity; FEVI, forced expiratory volume in 1 sec.
aPercent ofpredicted.
bMean oftwodeterminations; DNA adducts measurements were notavailable for eight workers.
clmmunostaining positive, all others negative.
FVC,%
no
112
116
85
91
125
95
92
98
90
129
98
110
94
95
107
91
107
91
104
84
95
114%
FEV,,%a
96
105
101
83
86
61
88
83
88
87
111
84
109
91
87
106
87
92
89
79
78
89
109
Adducts,b
fmole/4g DNA
0.15
0.20
0.19
0.25
0.07
0.09
0.20
0.21
0.10
0.11
0.17
0.19
0.12
0.44
0.23
DNA adducts ofcoke oven workers were compared with those
of eight unexposed workers. Among the coke-oven workers,
levels of adducts were compared by cigarette smoking status
(smoker, nonsmoker, ex-smoker), by pulmonary function, by
severity ofsputumcellsatypia, andbyjobtitle. All comparisons
were performed using rank-sum Wilcoxon test.
Cytomorphology andImmunostaining ofSputum
Cells
Sputum induction was performed by a 25-min inhalation of
sterile Hank's balanced salt solution following a standard pro-
cedure. For each subject eight glass slides were prepared and
fixed at the field center and then studied by Papanicolaou
method. The remaining material ofsputum was homogenized
andplaced inSaccomanno'spreservativesolution (2% polyethyl-
eneglycol in50% ethanol). Multipleslidesofeachsputumspeci-
men were stained separately to minimize the effect ofstaining
variability. Acompletedescriptionofthestainingprotocolused
inthisstudy canbefoundinprevious reports(7,8). Briefly, slides
were washedinphosphate-buffered saline (PBS), 0.01 M atpH
7.4, andincubatedwith SCLC orNSCLCantibodiesin asealed,
humidifiedchamberat roomtemperature(25°C). Diaminobenz-
idineimmunostaining wasenhancedby abiotinylatedsecondary
antibody solution (directed against the species/subclass ofim-
munoglobulin inwhichtheprimary antibody wasraised), and a
biotinylatedtertiary antibody solution(directedagainstthe sec-
ondary antibody) (7). Specimens werethencounterstained with
0.125% methylene blue and mounted by routine methods.
Monoclonalprimary antibodies (IgMwith specificity for agly-
colipidantigenofSCLC [codenumber624HI2] andIgGto apro-
teinantigenofNSCLC [codenumber703D4]) wereprovidedby
the Navy Oncology Branch ofthe National Cancer Institute.
Pulmonary Function Tests
Pulmonary function tests wereperformedusingprotocols and
equipment (Collins Survey II Spirometer interfaced with a
IBM/XTusing an S&MInstrumentCo. interface) suggestedby
Atherosclerosis RiskinCommunities Study (ARIC) andbased
ontherecommendedproceduresofAmericanThoracicSociety.
Results
The meanageofthe23coke-oven workers was40.83 (± 5.82)
years. A48-year-old subjectwithpositiveimmunostaining, mor-
phological atypia (moderate dysplasia), and severe airways
obstruction was identified. He was a current smokerandhehad
worked 14 years as a gas regulator.
PAH-DNA adducts levels were assessed for 15 coke-oven
workers (Table 1). Theadduct level ofthe subjectwith positive
immunostaining was similar to the mean of immunostaining
negativesubjects. MeansofPAH-DNAadducts in 15 coke-oven
workers (mean age: 41.7 ± 6.8) andcontrols (n = 8; mean age:
38.2 ± 8.9; 1 smoker, 7 nonsmokers) were, respectively, 0.188
(± 0.12) and0.146 (± 0.05) fmole/Ag DNA. No significant dif-
ference was detectedbetween groups. The means ofPAH-DNA
adducts by cigarette smoking habits, by pulmonary function
forcedexpiratory volumein 1 sec/forced vital capacity (FEVy/
FVC), bycytomorphologyandbyjobtitle arereported inTable
2. Although nosignificantdifferences wereobserved, smokers,
workers withFEV,/FVC .80%, and workerswithmorphologi-
caldysplasiaofsputum cellshad thehighestlevelofadducts. The
jobtitleof"gasregulator" showedthehighestvaluesofadducts.
Subject
A
B
C
D
E
Fc
G
H
I
J
K
L
M
N
0
p
Q
R
S
T
U
V
w
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Table2. MeansofPAH-DNAadductsof15coke-oven workers bycigarette
smoking habits, pulmonary function, cytomorphology, andjob title.
Parameter Na Mean (SD)
Cigarette smoking habits
Smokers 8 0.205 (±0.106)
Ex-smokers 5 0.151 (±0.075)
Nonsmokers 2 0.147 (±0.055)
Pulmonary function
FEVI/FVC <80% 9 0.186 (±0.114)
FEV,/FVC >80% 6 0.170 (±0.049)
Cytomorphology
Normal 3 0.128 (±0.063)
Squamous metaplasia 8 0.171 (±0.044)
Moderate dysplasia 4 0.235 (±0.156)
Job title
Bench 7 0.148 (±0.070)
Maintenance 2 0.200 (±0.205)
Supervisor 2 0.198 (±0.003)
Gas regulator 3 0.238 (±0.182)
Top side 1 0.146 -
Unexposed controls 8 0.141 (±0.050)
Abbreviations: FEVI, forced expiratory volume in I sec; FVC, forced vital
capacity.
aDNA adducts measurements were not available foreight workers.
Discussion
Recognition ofbiologic changes associated with carcinogen
exposureandwithlungcancerriskisimportantforlung cancer
prevention and forsuccessful early intervention (6,11,12). Inthis
survey two types ofbiologic indices have been measured: a) a
biologic indexoflungcancerriskassessedby frequency andin-
tensity ofavidin-biotincomplex immunostaining ofcell surface
lungcancerdifferentiationantigens (8); b)abiologic indexofex-
posure assessed by frequency and level ofPAH-DNA adducts
(13,14). Among 23 coke-oven workers, 1 subject was found to
have cell-surface lung-cancer differentiation antigens detected
by immunostaining. It is interesting that this subject was a
smoker, had a severe airways obstruction, and had moderate
dysplasia of bronchial epithelium cells. The role of cigarette
smoking and cellular atypia as factors associated with lung
cancer is well established. Tockmanetal. (15) andKulleretal.
(16) have independently found that airways obstruction can be
considered an independent riskfactorforlung cancerafterad-
justing for cigarette smoking. PAH-DNA adducts have been
measured in the peripheral white blood cells of coke-oven
workers andcontrols by ELISA. All thecoke-ovenworkersand
all the presumed unexposed noncoke-oven workers had detec-
table adducts levels. Other sources ofexposure (for example,
diet, smoking, airpollution) mayexplainthepresenceofadducts
of PAH in DNA of lymphocytes ofcontrols. No information
about charcoal-broiled food was obtained in this preliminary
survey. Themeanlevelofadductsinsmokersandinsubjectswith
FEV,/FVC . 80% wasmarginally higherthaninex-smokersor
nonsmokersandinworkerswithFEV,/FVC > 80%, respective-
ly; however, thedifferences werenotsignificant. Amongthejob
titles, the "gas regulators" exhibited the highest adduct level,
whilethejobtitleof"topside," consideredthemostexposedto
PAH, was represented by only one worker with adduct level
below the meansoftheotherjobtitles. However, alargeamount
ofinterindividual variation inadductlevels wasobservedamong
workers withthe samejobtitleandthesame smokinghabits. The
plannedsurveyprovidestheopportunitytoevaluatetheassocia-
tionofthesetwobiologicmonitoring methods, oneofcarcinogen
exposure (DNAadducts)andoneoflungcancer risk(immunos-
tainedcytology), inordertoexaminetheassociationbetweenef-
fectivegenomic carcinogen doseandtargetcell transformation.
This study is the first to evaluate the characteristics ofmono-
clonal antibody recognition ofcell-surface differentiation an-
tigens in the sputum cells ofa high-risk employment group.
This manuscript was presented asaposterattheConferenceon Biomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona, Hawaii, 26
October-I November 1991.
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